Altris.AI – The New Era of Retinal Diagnosis is Coming


(Altris, Inc) announced it has signed an agreement with a South Korean
ophthalmic and optical medical equipment manufacturer Huvitz
Co., Ltd.
aimed at the development of customized deep learning
solutions for retinal diseases detection unique for Huvitz HOCT-1/1F
device, All-in-One PC integrated 3D Optical Coherence Tomography (OCT)
and Fundus Camera.

Altris.AI’s OCT and Fundus algorithms have been trained using anonymized
OCT retinal scans as well as Fundus images collected during more than 12
years, and are able to detect more than 50 retinal diseases and
conditions. Currently, Altris.AI’s solution is available in web and
mobile version for structural retina analysis. The model shows the high
level of performance with multi-disease classification accuracy more
than 96%.

The main retinal conditions which Altris.AI model can detect:

• Normal retina;

• Dry Age-Related Macular Degeneration;

• Wet Age-Related Macular Degeneration;

• Diabetic Retinopathy;

• Retinal Hemorrhage;

• Retinal Detachment;

• Central Serous Retinopathy;

• Macular Pucker (Epiretinal Fibrosis);

• Degenerative Myopia;

• Vitreo-Macular Traction Syndrome;

• Vitreous Detachment;

• Macular Hole;

• Lamellar Macular Hole;

• Pseudohole;

• Central Retinal Vein Occlusion;

• Branch Retinal Vein Occlusion;

• Retinal Artery Occlusion;

• Pigment Choroidal Nevus;

• Solar Maculopathy;

• Chorioretinal scars;

• Vitelliform Dystrophy;

• Tapetoretinal Dystrophy;

• Retinitis Pigmentosa.

Altris.AI’s technology will complement Huvitz All-in-One 3D OCT and
Fundus Camera device by adding new features for diagnostic support and
automatic retinal diseases detection on OCT scans or Fundus images in
combination or separately, which allows ophthalmologists and
optometrists with basic knowledge to have higher level of performance as
an experienced retinal imaging specialist in just couple of clicks.

About Altris.AI

Altris.AI (Altris, Inc) is a company which applies computer vision and
deep learning trained algorithms to build innovative ophthalmology
diagnosis real-time support platform for the automatic, structural and
quantitative analysis and detection of glaucoma, age-related macular
degeneration, diabetic retinopathy and other retinal diseases on Optical
Coherence Tomography (OCT) scans and Fundus images by learning from a
large dataset of clinical cases. The company accumulated and legally
owns one of the most massive anonymized databases of the retina, optic
nerve scans, and images as well as clinical data. We continue increasing
our dataset daily in our ophthalmology center with OCT, OCT-Angio scans
and Fundus images.

For more information, please visit http://altris.ai

Follow us on Facebook
and LinkedIn


For Altris.AI (Altris, Inc)
Andrey Kuropyatnyk


I have been involved with publishing and marketing for the past 37 years. My passion is helping people share their voice. I am able to do this through two important venues: One, with Area-Info.net where people can share everything from opinions to events to news. It is your choice! What do you want to share? Two, through a new program called America's Real Deal I am involved with to help business owners get their voice heard.For people who love to save money and earn while saving, there is a new program called the r network. You are provided with a card that entitles the user to automatic savings on more than 300,000 products. Learn more about the revv card today. This is by invitation only to be some of the first people to get this card.I schedule speaking engagements with community groups and business groups to share my passion about the importance of "sharing your voice".Contact me directly at lee@leeeverton.com for scheduling information.